Ikena Oncology, Inc.
Tead inhibitors and uses thereof
Last updated:
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same.
Status:
Grant
Type:
Utility
Filling date:
29 May 2020
Issue date:
15 Mar 2022